Patent Assignment
Reel/Frame 030805/0023
Assignment of Assignor's Interest
Recorded: 2013-07-16
Pages: 8
Assignor
ABBOTT GMBH & CO KG
Executed: 2012-11-01
Assignee
ABBVIE DEUTSCHLAND GMBH & CO KG
MAX-PLANCK-RING 2A, WIESBADEN, 65205, GERMANY
Covered Properties
(63)
Amino Naphthyridine Compounds as Anti-Rhoumatic Agents.
Patent:
5,464,781 →
Application:
08/244,369 →
Antitumor Peptides
Patent:
5,831,002 →
Application:
08/472,453 →
Therapeutic Agents
Patent:
5,652,271 →
Application:
08/545,752 →
Condensed 4-Aminopyridines with Antirheumatic Activity
Patent:
5,780,482 →
Application:
08/564,154 →
Production of Fine Particle Dye or Drug Preparations
Patent:
5,700,471 →
Application:
08/573,876 →
Bicyclic Aromatic Compounds as Therapeutic Agents
Patent:
5,767,116 →
Application:
08/605,130 →
Therapeutic Agents
Patent:
5,760,035 →
Application:
08/615,202 →
Therapeutic Agents
Patent:
5,753,665 →
Application:
08/628,662 →
Therapeutic Agents Containing Thyroid Hormones
Patent:
5,753,254 →
Application:
08/682,783 →
2-(Aminoalkoxy) Phenylalkylamines with Antiinflammatory Activity
Patent:
5,736,568 →
Application:
08/687,584 →
Naphthyridinone Derivatives
Patent:
5,854,257 →
Application:
08/809,580 →
Naphthyridine Derivatives
Patent:
5,712,286 →
Application:
08/809,581 →
Process for Producing Sodium 1-Thyroxine Comprising the Oxidative Coupling of a Diido-1-Tyrosine Catalysed by a Manganese Salt in the Presence of an Amine
Patent:
5,917,087 →
Application:
08/817,325 →
Novel Carboxylic Acid Derivatives, Their Preparation and Use in Treating Cancer
Patent:
6,030,975 →
Application:
08/818,622 →
Dolastatin-15 Derivatives in Combination with Taxanes
Patent:
6,103,698 →
Application:
08/819,101 →
Dolastatin 15 Derivatives
Patent:
6,143,721 →
Application:
08/896,394 →
Phenooxy-,Phenylthio-,Benzoyl-Alkyleneaminoalkylene -Imidazole Derivativesas Therapeutic Agents
Patent:
6,031,109 →
Application:
09/050,396 →
Dolastatin-15 Derivatives in Combination with Taxanes
Patent:
6,632,795 →
Application:
09/520,254 →
Dolastatin 15 Derivatives
Patent:
6,458,765 →
Application:
09/618,694 →
Dispersions for the Formulation of Slightly or Poorly Soluble Agents
Method for Controlled Production of Ultrafine Microparticles and Nanoparticles
Patent:
8,202,540 →
Application:
10/030,417 →
Dolastatin 15 Derivatives
Antineoplastic Peptides
Dolastatin 15 Derivatives
Dispersions for the Formulation of Slightly or Poorly Soluble Agents
Method for Producing Ultrafine Submicronic Suspensions
Method for the Gentle Production of Ultrafine Particle Suspensions and Ultrafine Particles and the Use Thereof
Antineoplastic Peptides
Method and Device for Producing Very Fine Particles and Coating Such Particles
Powdered Protein Compositions and Methods of Making Same
Abuse Resistant Melt Extruded Formulation Having Reduced Alcohol Interaction
Application:
12/359,788 →
Publication:
US 2009/0317355
Antibodies Against the Rgm a Protein and Uses Thereof
Antibodies to Receptor of Advanced Glycation End Products (Rage) and Uses Thereof
A¿(X - 38 .. 43) oligomers, and processes, compositions, and uses thereof
Application:
12/509,315 →
Publication:
US 2010/0173828
Amyloid ¿ peptide analogues, oligomers thereof, processes for preparing and composi-tions comprising said analogues or oligomers, and their uses
Application:
12/509,325 →
Publication:
US 2011/0092445
Nanocrystals for Use in Topical Cosmetic Formulations and Method of Production Thereof
Abuse Resistant Melt Extruded Formulation Having Reduced Alcohol Interaction
Application:
12/631,010 →
Publication:
US 2010/0172989
Dolastatin 15 Derivatives
Metabolites and Derivatives of Ambrisentan
Heterocyclic Compounds, Pharmaceutical Compositions Containing Them, and Their Use in Therapy
Aminotetraline Derivatives, Pharmaceutical Compositions Containing Them, and Their Use in Therapy
Carboxamide Compounds and Their Use as Calpain Inhibitors
5-Halogen-Substituted Oxindole Derivatives and Use Thereof for Treating Vasopressin-Dependent Diseases
5,6-Disubstituted Oxindole-Derivatives and Use Thereof for Treating Vasopressin-Dependent Diseases
Heterocyclic Compounds and Their Use as Glycogen Synthase Kinase-3 Inhibitors
Modulators of 5-Ht Receptors and Methods of Use Thereof
Carboxamide Compounds and Their Use as Calpain Inhibitors
Benzenesulfonanilide Compounds Suitable for Treating Disorders That Respond to Modulation of the Serotonin 5-HT6 Receptor
Benzenesulfonanilide Compounds Suitable for Treating Disorders That Respond to Modulation of the Serotonin 5-HT6 Receptor
N-Phenyl- (Piperazinyl or Homopiperazinyl)-Benzenesulfonamide or Benzenesulfonyl-Phenl-(Piperazine or Homopiperazine) Compounds Suitable for Treating Disorders That Respond to Modulation of the Serotonin 5-HT6 Receptor
Carboxamide Compounds and Their Use as Calpain Inhibitors
Antineoplastic Peptides
Methods for Treating Psoriasis Using Antibodies That Bind to the P40 Subunit of Il-12 and/or Il-23
Modulators of 5-Ht Receptors and Methods of Use Thereof
Tetrahydroisoquinolines, Pharmaceutical Compositions Containing Them, and Their Use in Therapy
Carboxamide Compounds and Their Use as Calpain Inhibitors
1-(7-(Hexahydropyrrolo [3, 4-C] Pyrrol-2 (1H)-Yl) Quinolin-4-Yl) -3- (Pyrazin-2-Yl) Urea Derivatives and Related Compounds as Glycogen Synthase Kinase 3 (Gsk-3)
Method for Evaluating the Solubility of a Crystalline Substance in a Polymer
Pharmaceutical Dosage Form Comprising Polymeric Carrier Composition
Application:
13/001,060 →
Publication:
US 2011/0182891
N-Phenyl-(Piperazinyl or Homopiperazinyl)-Benzenesulfonamide or Benzenesulfonyl-Phenyl-(Piperazine or Homopiperazine) Compounds Suitable for Treating Disorders That Respond to Modulation of the Serotonin 5-HT6 Receptor
Dolastatin 15 Derivatives
Application:
13/447,529 →
Publication:
US 2013/0046077
N-Phenyl-(Piperazinyl or Homopiperazinyl)-Benzenesulfonamide or Benzenesulfonyl-Phenyl-(Piperazine or Homopiperazine) Compounds Suitable for Treating Disorders That Respond to Modulation of the Serotonin 5-HT6 Receptor
Application:
13/618,865 →
Publication:
US 2013/0018047
Antibodies to Receptor of Advanced Glycation End Products (Rage) and Uses Thereof
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 31, 1996
From: KHAN, KARRAR AHMAD; SMITH, ALAN
To: KNOLL AKTIENGESELLSCHAFT
Reel/Frame 008173/0526 →
Security Agreement
Aug 29, 1996
From: CIRRUS LOGIC, INC.
To: BANK OF AMERICA NATIONAL TRUST & SAVINGS ASSOCIATION AS AGENT
Reel/Frame 008113/0001 →
Assignment of Assignor's Interest
Jul 27, 2001
From: MULLER, RAINER H.
To: PHARMASOL GMBH
Reel/Frame 012031/0845 →
Corrective Assignment to Correct the Assignee Address. Document Previously Recorded on Reel 013758 Frame 0551, Assignor Confirms the Assignment of the Entire Interest.
Sep 9, 2003
From: KNOLL AKTIENGESELLSCHAFT
To: ABBOTT GMBH & CO. KG
Reel/Frame 014455/0058 →
Assignment of Assignor's Interest
Jun 21, 2006
From: BOOTS COMPANY, PLC, THE
To: ABBOTT GMBH & CO. KG
Reel/Frame 017823/0566 →
Assignment of Assignor's Interest
Mar 11, 2008
From: BASF AKTIENGESELLSCHAFT
To: ABBOTT GMBH & CO. KG
Reel/Frame 020635/0232 →
Assignment of Assignor's Interest
Jun 24, 2008
From: PHARMASOL GMBH
To: ABBOTT GMBH & CO., KG
Reel/Frame 021138/0602 →
Assignment of Assignor's Interest
May 21, 2009
From: BASF SE
To: ABBOTT GMBH & CO. KG
Reel/Frame 022714/0569 →
Certificate Concerning Legal Succession
May 21, 2009
From: BASF AKTIENGESELLSCHAFT
To: BASF SE
Reel/Frame 022714/0557 →
Assignment of Assignor's Interest
Dec 28, 2009
From: JANSSEN, BERND; BARLOZZARI, TERESA; HAUPT, ANDREAS; ZIERKE, THOMAS
To: BASF AKTIENGESELLSCHAFT
Reel/Frame 023705/0648 →
Assignment of Assignor's Interest
Dec 28, 2009
From: BASF AKTIENGESELLSCHAFT
To: ABBOTT GMBH & CO. KG
Reel/Frame 023705/0717 →
Assignment of Assignor's Interest
Jan 12, 2010
From: JANSSEN, BERND; BARLOZZARI, TERESA; HAUPT, ANDREAS; ZIERKE, THOMAS
To: BASF AKTIENGESELLSCHAFT
Reel/Frame 023765/0410 →